Cargando…
Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia
L-asparaginase, which hydrolyzes asparagine into aspartic acid and ammonia, is frequently used to treat acute lymphoblastic leukaemia in children. When combined with other chemotherapy drugs, the event-free survival rate is 90%. Due to immunogenicity and drug resistance, however, not all patients be...
Autores principales: | Zhou, Ruizhi, Liang, Tianqi, Li, Tianwen, Huang, Junbin, Chen, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929349/ https://www.ncbi.nlm.nih.gov/pubmed/36816964 http://dx.doi.org/10.3389/fonc.2023.1070069 |
Ejemplares similares
-
Alterations in cellular metabolisms after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review
por: Li, Chunmou, et al.
Publicado: (2022) -
Acute myeloid leukaemia niche regulates response to L‐asparaginase
por: Kaspers, Gertjan J. L.
Publicado: (2019) -
Arginase: Mechanisms and Clinical Application in Hematologic Malignancy
por: Du, Zefan, et al.
Publicado: (2022) -
A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition
por: Tan, Yan Qi, et al.
Publicado: (2023) -
Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion
por: Baruchel, André, et al.
Publicado: (2020)